219 related articles for article (PubMed ID: 4145715)
1. The fate of noradrenaline in the sympathetic neurone.
Axelrod J
Harvey Lect; 1973; 67():175-97. PubMed ID: 4145715
[No Abstract] [Full Text] [Related]
2. Molecular geometry and adrenergic drug activity.
Patil PN; Miller DD; Trendelenburg U
Pharmacol Rev; 1974 Dec; 26(4):323-92. PubMed ID: 4156804
[No Abstract] [Full Text] [Related]
3. Catecholamines.
Axelrod J; Weinshilboum R
N Engl J Med; 1972 Aug; 287(5):237-42. PubMed ID: 4402575
[No Abstract] [Full Text] [Related]
4. Proceedings: Intraneuronal distributions and metabolic pathways of the adrenergic neurotransmitter.
Stéfano FJ
Acta Physiol Lat Am; 1973; 23(6):626-8. PubMed ID: 4369053
[No Abstract] [Full Text] [Related]
5. [Metabolism and pathology of catecholamines].
Traba ML
Rev Clin Esp; 1981 Jul 15-31; 162(1-2):5-13. PubMed ID: 6117933
[No Abstract] [Full Text] [Related]
6. Regulation of catecholamine turnover by variations of enzyme levels.
Pletscher A
Pharmacol Rev; 1972 Jun; 24(2):225-32. PubMed ID: 4404611
[No Abstract] [Full Text] [Related]
7. Adrenergic neurotransmitter storage and release.
Von Euler US
Hawaii Med J; 1974 Oct; 33(10):371-5. PubMed ID: 4376551
[No Abstract] [Full Text] [Related]
8. Regulation of norepinephrine contents in cardiac sympathetic neuron during high impulse activity: alterations in monoamine oxidase activity.
Bhagat BD
Recent Adv Stud Cardiac Struct Metab; 1973; 3():343-56. PubMed ID: 4806659
[No Abstract] [Full Text] [Related]
9. The effect of prolonged vasopressin administration on the level and metabolism of catecholamines in the rat brain and kidneys.
Szmigielska H
Acta Physiol Pol; 1976; 27(3):259-64. PubMed ID: 7918
[TBL] [Abstract][Full Text] [Related]
10. Studies of neurotransmitter release in the pathogenesis of hypertension.
Louis WJ; Jarrott B; Burnstock G; Watanabe H
Contrib Nephrol; 1977; 8():182-9. PubMed ID: 19200
[TBL] [Abstract][Full Text] [Related]
11. Organ culture of rat superior cervical ganglia.
Brown JH; Nelson DL; Molinoff PB
J Pharmacol Exp Ther; 1977 May; 201(2):298-311. PubMed ID: 16118
[TBL] [Abstract][Full Text] [Related]
12. [High blood pressure, catecholamines and the sympathetic nervous system. I. Molecular-pharmacological insights].
Offerhaus L
Ned Tijdschr Geneeskd; 1975 Jan; 119(4):144-53. PubMed ID: 236521
[No Abstract] [Full Text] [Related]
13. [The monoamines in molluscs. I. Catecholamines: biosynthesis, disposition and inactivation (author's transl)].
Cardot J
J Physiol (Paris); 1979; 75(7):689-713. PubMed ID: 44729
[TBL] [Abstract][Full Text] [Related]
14. Abnormal catecholamine metabolism in pheochromocytoma.
Rubio MC; Barontini MB
Medicina (B Aires); 1985; 45(6):631-6. PubMed ID: 2878347
[No Abstract] [Full Text] [Related]
15. [Sympatho-neuronal and sympatho-adrenal activity in experimental and essential hypertension].
Grobecker H
Verh Dtsch Ges Kreislaufforsch; 1977; 43():2-9. PubMed ID: 26147
[No Abstract] [Full Text] [Related]
16. [Modern achievements in the field of catecholamine biochemistry].
Gorkin VZ
Vopr Med Khim; 1974 May; 20(3):227-38. PubMed ID: 4152064
[No Abstract] [Full Text] [Related]
17. Sympathetic physiology and pharmacology.
Richardson KT
Surv Ophthalmol; 1972; 17(2):120-31. PubMed ID: 4153492
[No Abstract] [Full Text] [Related]
18. Distribution and properties of adrenergic storage vesicles in nerve terminals.
Nelson DL; Molinoff PB
J Pharmacol Exp Ther; 1976 Feb; 196(2):346-59. PubMed ID: 1255482
[TBL] [Abstract][Full Text] [Related]
19. Effects of axonal injury on norepinephrine, tyrosine hydroxylase and monoamine oxidase levels in sympathetic ganglia.
Cheah TB; Geffen LB
J Neurobiol; 1973; 4(5):443-52. PubMed ID: 4147762
[No Abstract] [Full Text] [Related]
20. [The state of the sympathetic-adrenal system in congestive heart failure].
Korochkin IM; Oganov RG
Kardiologiia; 1973 Mar; 13(3):140-51. PubMed ID: 4146159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
